ロード中...
SURG-30. DOES LEVETIRACETAM ACT AS A TEMOZOLOMIDE CHEMOSENSITIZER IN PATIENTS WITH GLIOBLASTOMA?
BACKGROUND: In a recent study, patients with glioblastoma (GBM) who administered Levetiracetam (LEV) during chemoradiotherapy were reported to have survival benefit. However, the effect of LEV on survival of glioblastoma patients is not well known. METHODS: From 2004 to 2016, 340 patients with surgi...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692441/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.984 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|